​TheraB Medical Products Secures Strategic Investments from Multiple Early Stage Venture Funds

[LANSING, MI] – TheraB Medical, a leading medical technology company specializing in neonatal care solutions, is thrilled to announce that they have secured investment from several venture capital firms that have joined their mission to revolutionize neonatal care. Participating investors include Suncoast Ventures, Smartgate VC, Baker Bridge Capital and Triple S Ventures, plus follow on funds from Michigan Rise and Wisconsin River Business Angels. With these investments, TheraB has closed nearly 60% of their current Seed funding round. 

These investments mark a significant milestone in TheraB Medical's journey to revolutionize neonatal care. The funds raised will be instrumental in advancing the development and commercialization of TheraB's flagship product, SnugLit—a portable and wearable phototherapy device designed to treat infant jaundice while keeping baby in the arms of their parents throughout treatment. 

“We are thrilled to participate in TheraB Medical’s most recent Seed funding round,” said Avag Simonyan, Managing Partner ats 3S Ventures. “Their innovative approach and dedication have profoundly impressed us, and we believe in the potential of their vision to reshape the industry. We look forward to a successful partnership and are eager to see them reach new heights.”

“We are excited about TheraB because it’s a much needed innovation for a very large and widespread global problem which is treating infant jaundice,” said Genevieve LeMarchal, Managing Partner at Suncoast Ventures. “Alexa and her team worked directly with the nurses to ideate and design this product, and it really shows in the simplicity and utility of the product. We’re excited to back TheraB and to see what the future holds for the SnugLit.”

TheraB Medical is committed to delivering groundbreaking medical devices that enhance neonatal healthcare and improve patient experiences. With the support of these esteemed investors, TheraB is poised for continued growth and success in its pursuit of better healthcare for the smallest and most vulnerable patients.

For more information about TheraB Medical and its innovative solutions, please visit www.therabmedical.com.
-------------------------------------------------

About TheraB Medical:
TheraB Medical is a medical technology company focused on improving neonatal care. The company's flagship product, SnugLit, is a portable and wearable phototherapy device designed for the treatment of infant jaundice. TheraB Medical is dedicated to enhancing the health and well-being of infants and children through innovative medical devices.

Contact: 
Alexa Jones, CEO, TheraB Medical
 Alexa.jones@therabmedical.com

Previous
Previous

TheraB Medical Secures Additional Strategic Investment From Foster Lane Investments, LLC

Next
Next

​TheraB Medical Products Welcomes New Clinical Advisor, Dr. David K. Stevenson, MD, and Expands Relationship with Stanford University